Results 61 to 70 of about 12,958 (242)

Evidence that Moved Psychedelic Medicine from the Fringe to the Mainstream in 2022

European Psychiatry, 2023
Interest in possible clinical uses for psychedelic drugs has grown steadily over the past decade. Although impressive findings from small studies stimulated considerable speculation and provided a strong justification for further study of psychedelic ...
M. Bogenschutz
doaj   +1 more source

On Minimizing Risk and Harm in the Use of Psychedelics

Psychiatric Research and Clinical Practice
Objective This article outlines recommendations from 30 psychedelic researchers on how to create a better psychedelic safety net. Methods A survey of 30 psychedelic researchers asked them to identify key critical research gaps around psychedelic harm and
Jules Evans, Marc Aixalà, Brian T. Anderson, William Brennan, Rebecka Bremler, Joost J. Breeksema, Lisa Burback, Abigail E. Calder, Robin L. Carhart‐Harris, Katherine Cheung, Neşe Devenot, Ingmar Gorman, Jakub Greń, Peter S. Hendricks, Brian Holoyda, Edward Jacobs, Joy Krecké, Daniel J. Kruger, David Luke, Tomislav Majić, Amy L. McGuire, Nicky J. Mehtani, David S. Mathai, Kristin Nash, Tehseen Noorani, Roman Palitsky, Oliver C. Robinson, Otto Simonsson, Elin Stahre, Michiel vanElk, David B. Yaden   +30 more
doaj   +1 more source

Unlocking ‘stuckness’ and catalysing change: A qualitative study of clinician and service leader perspectives on psychedelic‐assisted therapy for substance use and mental health problems

Addiction, EarlyView.
Abstract Background and aims Australia recently down‐scheduled and authorised psychedelic‐assisted therapies, including psilocybin, for certain mental health conditions. Evidence is emerging for potential application in substance use disorder treatment. However, regulatory developments have outpaced implementation readiness.
Sarah J. Catchlove, Katrin Oliver, Michael Savic, Shalini Arunogiri   +3 more
wiley   +1 more source

Perceived attachment history predicts psychedelic experiences : A naturalistic study

Background and aims: Emerging research indicates that psychedelics may have therapeutic potential by fostering meaningful experiences that act as in fl ection points in people ' s narratives of personal development.
Mikulincer, Mario, Granqvist, Pehr,, Gruneau Brulin, Joel,, Mario Mikulincer, Joel Gruneau Brulin, Cherniak, Aaron,, Aaron D. Cherniak, Pehr Granqvist   +7 more
core   +1 more source

Drug sellers' use of a drug checking service amid the overdose crisis in British Columbia, Canada

Addiction, EarlyView.
Abstract Aims This study examined the use of a drug checking service by drug sellers in British Columbia, Canada, to assess motivations for service use and substances intended for distribution, focusing on risks associated with an unstable illicit drug market.
Pablo Gonzalez‐Nieto, Bruce Wallace, Collin Kielty, Irene Shkolnikov, Ava Margolese, Jaime Arredondo Sanchez Lira, Chris Gill, Dennis Hore   +7 more
wiley   +1 more source

Psychedelic Memories

, 2022
Expertimental study on psychedelic memories and meaning in ...
Otto Simonsson
core   +1 more source

Synergistic behavioral and neuroplastic effects of psilocybin-NMDAR modulator administration

Translational Psychiatry
The full therapeutic potential of serotonergic psychedelics (SP) in treating neuropsychiatric disorders, such as depression and schizophrenia, is limited by possible adverse effects, including perceptual disturbances and psychosis, which require ...
Tom Ben-Tal, Ilana Pogodin, Alexander Botvinnik, Tzuri Lifschytz, Uriel Heresco-Levy, Bernard Lerer   +5 more
doaj   +1 more source

The Birth of the Psychedelic Industry: Capitalizing on the Psychedelic Renaissance

Future Humanities
ABSTRACTThe resurgence of psychedelic medicine, often termed ‘the psychedelic renaissance,’ marks a profound shift from decades of repressed research to a burgeoning field characterised by significant scientific, regulatory, and economic transformations. Once marginalised, psychedelics are now experiencing widespread interest and investment, spurred by
Minsu Yoo, Sofia Sakopoulos
openaire   +1 more source

Factors associated with readmission to residential treatment among clients transitioned from detoxification services in Alberta, Canada

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Readmission to residential treatment increases healthcare costs, strains publicly funded systems, and may not adequately meet clients' needs. This study examined rates and predictors of readmission to residential treatment among clients transitioned from detoxification services.
Abreham Mekonnen
wiley   +1 more source

Psychedelic-like Activity of Norpsilocin Analogues

Primary metabolites of mushroom tryptamines, psilocybin and baeocystin (i.e., psilocin and norpsilocin), exhibit potent agonist activity at the serotonin 2A receptor (5-HT2A) in vitro but differ in their 5-HT2A-mediated effects in vivo.
Elise K. Burkhartzmeyer (16033367), Michael H. Baumann (8785529), Alexander M. Sherwood (3395678), Grant C. Glatfelter (10277528), Samuel E. Williamson (4436167)   +4 more
core   +1 more source